References
- Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis: part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis. J Am Acad Dermatol. 2013; 69:173.e1-13.10.1016/j.jaad.2013.05.003
- Ferrandiz-Pulido C, Garcia-Patos V. A review of causes of Stevens–Johnson syndrome and toxic epidermal necrolysis in children. Arch Dis Child [Internet]. 2013 Jul 19 [cited 2013 Aug 21]; Available from: http://adc.bmj.com/content/early/2013/07/18/archdischild-2013-303718
- Borchers AT, Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Stevens–Johnson syndrome and toxic epidermal necrolysis. Autoimmun Rev. 2008; 7:598-605.10.1016/j.autrev.2008.06.00418603022
- Singalavanija S, Limpongsanurak W. Stevens-Johnson syndrome in Thai children: a 29-year study. J Med Assoc Thai. 2011; 94(Suppl 3):S85-90.22043758
- Hamilton GM, Fish J. Pediatric toxic epidermal necrolysis: an institutional review of patients admitted to an intensive care unit. J Burn Care Res Off Publ Am Burn Assoc. 2013; 34; e351-8.10.1097/BCR.0b013e31827a2ac3
- Kirchhof MG, Miliszewski MA, Sikora S, Papp A, Dutz JP. Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine. J Am Acad Dermatol. 2014; 71:941-7.10.1016/j.jaad.2014.07.01625087214
- Manuyakorn W, Siripool K, Kamchaisatian W, Pakakasama S, Visudtibhan A, Vilaiyuk S, et al. Phenobarbital-induced severe cutaneous adverse drug reactions are associated with CYP2C19*2 in Thai children. Pediatr Allergy Immunol. 2013; 24: 299-303.2355124110.1111/pai.12058
- Błaszczyk B, Szpringer M, Czuczwar SJ, Lasoń W. Single centre 20 year survey of antiepileptic druginduced hypersensitivity reactions. Pharmacol Rep PR. 2013; 65:399-409.10.1016/S1734-1140(13)71015-6
- Su P, Aw CWD. Severe cutaneous adverse reactions in a local hospital setting: a 5-year retrospective study. Int J Dermatol. 2014; 53:1339-45.10.1111/ijd.12118